RT Journal
A1 Schomer DL, Lewis RJ
T1 STopping seizures early and the surgical epilepsy trial that stopped even earlier
JF JAMA
JO JAMA
YR 2012
FD March 7
VO 307
IS 9
SP 966
OP 968
DO 10.1001/jama.2012.251
UL http://dx.doi.org/10.1001/jama.2012.251
AB 
Epilepsy, a common chronic neurological disorder, literally means “recurrent seizures” and affects approximately 1% to 1.5% of the population.1 Approximately 30% of individuals with epilepsy continue to experience seizures despite using antiepileptic drugs (AEDs).2 Many patients have serious adverse effects from the use of AEDs. Those with refractory epilepsy are forced to endure the risk of sudden unexpected (unexplained) death from epilepsy or premature death from other causes.3- 4